Patents by Inventor Sean Colgan

Sean Colgan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modulation of Inflammation Related to Columnar Epithelia
    Publication number: 20080064660
    Abstract: This invention provides pharmaceutical compositions containing lipoxin compounds and therapeutic uses for the compounds in treating or preventing a disease or condition associated with columnar epithelial inflammation. The invention also discloses methods for screening for compounds useful in preventing columnar epithelial inflammation.
    Type: Application
    Filed: August 13, 2007
    Publication date: March 13, 2008
    Inventors: James Madara, Charles Serhan, Sean Colgan
  • Novel approach to antimicrobial host defense with molecular shields with EPA and DHA analogs
    Publication number: 20060128804
    Abstract: Methods to cause tissue, such as mucosal cells, to express increased amounts of bactericidal permeability increasing protein (BPI) are described. Various BPI inducing agents include icosapentanoic acid (EPA) analogs and docosahexaenoic acid (DHA) analogs.
    Type: Application
    Filed: February 14, 2006
    Publication date: June 15, 2006
    Inventors: Charles Serhan, Sean Colgan
  • Compositions and methods for treating hematologic malignancies and multiple drug resistance
    Publication number: 20050203036
    Abstract: Methods and compositions are provided for treating a subject having or at risk of developing a hematologic malignancy and/or multiple drug resistance.
    Type: Application
    Filed: October 25, 2001
    Publication date: September 15, 2005
    Applicant: The Brigham and Women's Hospital, Inc.
    Inventor: Sean Colgan
  • Novel functions for decay accelerating factor (DAF) in inflammation
    Publication number: 20050169914
    Abstract: The invention involves methods and products for interfering with neutrophil transmigration and treating inflammatory conditions. Agents that bind decay accelerating factor (DAF) and agents that mimic SCR-3 epitope of DAF are provided.
    Type: Application
    Filed: August 2, 2004
    Publication date: August 4, 2005
    Inventors: Sean Colgan, Gregory Stahl